Carregant...
Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia
BACKGROUND: Tyrosine kinase inhibitors (TKIs) improve survival of chronic myeloid leukemia (CML) patients dramatically; however, non-adherence to TKI therapy may lead to resistance to the therapy. They are very expensive and covered under Part D insurance for Medicare patients. The impact of low-inc...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5764158/ https://ncbi.nlm.nih.gov/pubmed/28976559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31050 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|